Web Date: March 21, 2016
Former employees top Thermo Fisher offer for Affymetrix
A group of former Affymetrix employees hopes to scuttle Thermo Fisher Scientific’s planned $1.3 billion acquisition of the genetic analysis firm with an eleventh-hour $1.5 billion all-cash bid backed by a Chinese private equity firm. However, Affymetrix’ board has rejected the new deal.
“Our offer presents a compelling opportunity for Affymetrix’ stockholders to realize superior value through an attractive premium,” says Wei Zhou, president of Origin . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society